MOMENTA PHARMACEUTICALS INC 4
4 · MOMENTA PHARMACEUTICALS INC · Filed Sep 15, 2015
Insider Transaction Report
Form 4
Franken Michael
President, Biosimilars Busines
Transactions
- Sale
Common Stock
2015-09-11$18.92/sh−513$9,706→ 38,488 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2014.